Upgrade to SI Premium - Free Trial

Incyte's (INCY) Hodgkin Lymphoma Treatment Receives FDAOrphan Drug Designation

April 30, 2015 9:07 AM
Incyte (NASDAQ: INCY) received orphan ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles